IGNITE: Imagining Transformative Equity Research's Fundraising Page

 Conquer cancer  with  your Giving Page
Conquer cancer with your Giving Page

WHY WE'RE FUNDRAISING WITH THE JIMMY FUND WALK TO FIGHT CANCER

 

Thank you for considering a gift to IGNITE. We are the first pediatric oncology health equity research consortium—a research infrastructure that will catalyze bold, innovative approaches to research that challenges the status quo and establishes health equity science as an integrated priority across pediatric oncology nationally. Our mission is to reduce outcome disparities via the rapid development and evaluation of evidence-based health equity interventions.

 

The rarity of childhood cancer means that the field of pediatric oncology relies on large, multicenter cooperative group trials to improve survival outcomes. As a result, addressing identified disparities in this context requires health equity interventions that are scalable across cooperative clinical trial groups (e.g., the Children’s Oncology Group) to allow for the evaluation of efficacy in reducing disparities. From a logistical standpoint, this requires establishing a pipeline and feasibility testing framework within which to develop and evaluate health equity interventions. This is analogous to the familiar early-phase drug pipeline and consortia, which evaluate drugs for safety and initial signals of effect before running large, randomized controlled trials of efficacy. Currently, there is no existing research infrastructure in which to similarly develop, refine, and evaluate the feasibility of health equity interventions.

 

Our innovative research is possible through the support of donors and foundations. Any gift, no matter the size, advances our research mission to improve outcomes for every child with cancer. All donations are tax deductible and will directly support IGNITE research efforts.

 

To contribute by check, please write "IGNITE Giving Page" in the memo line, and send to:

            Giving Pages

            Dana-Farber Cancer Institute

            Division of Development & The Jimmy Fund

            10 Brookline Place West, 6th Fl

            Brookline, MA 02445

            617-632-6247

 

​For further assistance, you may also contact:

Kelsey Cunningham

Telephone: (857) 215-0297

kelseyn_cunningham@dfci.harvard.edu

 

PROGRESS TO GOAL

Raised:$10,000
Goal:$0
1team member

THANK YOU TO OUR TEAM MEMBERS

C = Team Captain
NAME
AMOUNT RAISED
x0x
x$10,000.00x

THANK YOU TO OUR TEAM DONORS

NAME
AMOUNT
Event Honor Roll
Caiden's Crusaders
$5,000
The Caiden's Crusaders, Inc.
I'm Living Proof buttons
Every dollar raised helps fuel Dana-Farber Cancer Institute's mission.
Together, we can defy cancer!














My Giving Page

 Conquer cancer  with  your Giving Page
Conquer cancer with your Giving Page

IGNITE: Imagining Transformative Equity Research

 

Thank you for considering a gift to IGNITE. We are the first pediatric oncology health equity research consortium—a research infrastructure that will catalyze bold, innovative approaches to research that challenges the status quo and establishes health equity science as an integrated priority across pediatric oncology nationally. Our mission is to reduce outcome disparities via the rapid development and evaluation of evidence-based health equity interventions.

 

The rarity of childhood cancer means that the field of pediatric oncology relies on large, multicenter cooperative group trials to improve survival outcomes. As a result, addressing identified disparities in this context requires health equity interventions that are scalable across cooperative clinical trial groups (e.g., the Children’s Oncology Group) to allow for the evaluation of efficacy in reducing disparities. From a logistical standpoint, this requires establishing a pipeline and feasibility testing framework within which to develop and evaluate health equity interventions. This is analogous to the familiar early-phase drug pipeline and consortia, which evaluate drugs for safety and initial signals of effect before running large, randomized controlled trials of efficacy. Currently, there is no existing research infrastructure in which to similarly develop, refine, and evaluate the feasibility of health equity interventions.

 

Our innovative research is possible through the support of donors and foundations. Any gift, no matter the size, advances our research mission to improve outcomes for every child with cancer. All donations are tax deductible and will directly support IGNITE research efforts.

 

To contribute by check, please write "IGNITE Giving Page" in the memo line, and send to:

            Giving Pages

            Dana-Farber Cancer Institute

            Division of Development & The Jimmy Fund

            10 Brookline Place West, 6th Fl

            Brookline, MA 02445

            617-632-6247

 

​For further assistance, you may also contact:

Kelsey Cunningham

Telephone: (857) 215-0297

kelseyn_cunningham@dfci.harvard.edu

 

View More
View More